Você procurou por: carcinoid (Inglês - Maltês)

carcinoid tumour
tumur karċinojde

carcinoid tumour:
tumur karċinojdi:

functional carcinoid tumours
tumuri karċinojdi funzjonali

therefore, the safety and efficacy of afinitor in patients with functional carcinoid tumours have not been established.
għaldaqstant, is-sigurtà u l-effikaċja ta’ afinitor f’pazjenti b’tumuri karċinojdi funzjonali ma ġewx stabbiliti.

included are hairy cell leukaemia, chronic myelogenous leukaemia, multiple myeloma, follicular lymphoma, carcinoid tumour, and malignant melanoma.
inklużi hemm il- lewkimja tal-hairy cell, lewkimja tal-mudullun kronika, majeloma multipla, limfoma follikulari, tumur karċinojde u melanoma malinna.

carcinoid tumour (a tumour of the endocrine system that produces hormones); malignant melanoma (a type of skin cancer affecting cells called melanocytes).
tumur karċinojdu (tumur tas-sistema endokrinali li tipproduċi l-ormoni); melanoma malinja (tip ta’ kanċer tal-ġilda li jaffettwa ċ-ċelloli msejħa melanocytes).

in a randomised, double-blind, multi-centre trial in patients with functional carcinoid tumours, afinitor plus depot octreotide was compared to placebo plus depot octreotide.
waqt prova randomizzata, double-blind, multiċentrika fost pazjent b’tumuri karċinojdi funzjonali, afinitor flimkien ma’ depot octreotide tqabbel ma’ plaċebo flimkien ma’ depot octreotide.

introna is used as an add-on to anticancer treatments, • carcinoid tumour (a tumour of the endocrine system that produces hormones), • malignant melanoma (a type of skin cancer affecting cells called melanocytes).
introna hija użata bħala addizzjoni mat - trattamenti kontra l- kanċer. • tumur karċinojdu (tumur tas- sistema endokrinali li tipproduċi l- ormoni), • melanoma malinja (tip ta ’ kanċer tal- ġilda li jaffettwa ċ- ċelloli msejħa melanocytes).